Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Davis, P.
Right arrow Articles by Sugimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, P.
Right arrow Articles by Sugimura, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 30:322-331 (2000)
© 2000 Foundation for Promotion of Cancer Research

Report of the Thirteenth International Symposium of the Foundation for Promotion of Cancer Research: Cancer Screening—Past, Present and Future

Peter Davis1, Matti Hakama2, Shigeru Hisamichi3, Tadao Kakizoe1, Takeshi Sano1 and Takashi Sugimura1,+

1National Cancer Center, Tokyo, Japan, 2University of Tampere, Tampere, Finland and 3Tohoku University School of Medicine, Sendai, Japan


   INTRODUCTION
 
The Thirteenth International Symposium of the Foundation for the Promotion of Cancer Research was entitled ‘Cancer Screening—Past, Present and Future’ and was held in Tokyo on April 26–28, 2000. The symposium was organized by Drs Tadao Kakizoe, Matti Hakama, Shigeru Hisamichi and Takeshi Sano with Dr Takashi Sugimura as advisor.


   OPENING
 
Chairperson: Dr Shigeru Hisamichi

Dr Sugimura (National Cancer Center, Tokyo) opened the symposium with a welcome address and a review of the previous symposia, which have looked at fundamental and clinical research in organ-specific cancer and his personal view of cancer screening (1,2). Since 1981, cancer has been the leading cause of death in Japan and there are many questions relating to early detection and treatment. The role of multistage carcinogenesis has been raised, leading to a progression from normal tissue to precancerous lesions and early cancer with its relationship to the timing of detection (. . . [Full Text of this Article]


   SESSION 1
 
1. General View
2. Evaluation of Screening Effectiveness
2.1. Methodology to evaluate cancer screening
2.2 Cost effectiveness of cancer screening

   SESSION 2: ORGAN-SPECIFIC ASPECTS
 
1. Colorectal Cancer Screening
2. Prostate Cancer Screening
3. Breast Cancer Screening
4. Lung Cancer Screening
5. Gastric Cancer Screening
6. Cervical Cancer Screening
7. Pancreatic Cancer Screening

   SESSION 3: PERSPECTIVES OF CANCER SCREENING
 
1. Novel Approach
1.1. Development of screening technology
1.2. Tumour markers for screening
1.3. Identification of high-risk population by genetic diagnosis
2. Management of Cancer Screening

   SUMMARY OF SYMPOSIUM
 

   Acknowledgements
 

   FOOTNOTES
 

   REFERENCES
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
F. Emura, D. Saito, T. Kakizoe, and M. J. Blaser
Infection, Cancer and Prevention: Report of the 19th International Symposium of the Foundation for Promotion of Cancer Research
Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 745 - 755.
[Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
P. S. Multani, K. Tobinai, T. Kakizoe, J. O. Armitage, R. Ohno, and T. Sugimura
Report of the Fifteenth International Symposium of the Foundation for Promotion of Cancer Research: New Horizons in the Diagnosis and Treatment of Hematological Malignancies Based on Molecular Genetic Features
Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 371 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
J. Collins, N. Shimoyama, E. Bruera, F. Takeda, T. Kakizoe, and T. Sugimura
Report of the Fourteenth International Symposium of the Foundation for Promotion of Cancer Research: Pain Control, Palliative Medicine and Psycho-oncology
Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 459 - 468.
[Full Text] [PDF]